Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the ‘VEDERA’ trial

Shukla, R, Emery, P orcid.org/0000-0002-7429-8482 and Buch, MH orcid.org/0000-0002-8962-5642 (2021) Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the ‘VEDERA’ trial. Rheumatology. ISSN 1462-0324

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. This is an author produced version of a letter published in Rheumatology. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published (online): 19 October 2021
  • Accepted: 8 October 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 26 Nov 2021 10:38
Last Modified: 19 Oct 2022 00:17
Status: Published online
Publisher: Oxford University Press (OUP)
Identification Number: 10.1093/rheumatology/keab766
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)